Galenica Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Galenica wird ein jährliches Gewinn- und Umsatzwachstum von 5.3% bzw. 4.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12% betragen.
Wichtige Informationen
5.3%
Wachstumsrate der Gewinne
6.0%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 25.0% |
| Wachstumsrate der Einnahmen | 4.2% |
| Zukünftige Eigenkapitalrendite | 12.0% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 25 Oct 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Galenica AG's (VTX:GALE) Popularity With Investors Is Under Threat From Overpricing
Nov 12
Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Oct 05Galenica (VTX:GALE) Might Have The Makings Of A Multi-Bagger
Sep 17Earnings Not Telling The Story For Galenica AG (VTX:GALE)
Jul 31Is Galenica (VTX:GALE) Using Too Much Debt?
Jun 16Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected
Apr 25We Think The Compensation For Galenica AG's (VTX:GALE) CEO Looks About Right
Apr 04Slowing Rates Of Return At Galenica (VTX:GALE) Leave Little Room For Excitement
Mar 29Pinning Down Galenica AG's (VTX:GALE) P/E Is Difficult Right Now
Jan 22Is There An Opportunity With Galenica AG's (VTX:GALE) 42% Undervaluation?
Jan 04Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Oct 26Is Galenica (VTX:GALE) Using Too Much Debt?
Oct 11Are Investors Undervaluing Galenica AG (VTX:GALE) By 42%?
Sep 26These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Jun 20Here's What To Make Of Galenica's (VTX:GALE) Decelerating Rates Of Return
Apr 17We Think Galenica (VTX:GALE) Can Stay On Top Of Its Debt
Mar 12Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Jan 08These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Nov 28The Returns At Galenica (VTX:GALE) Aren't Growing
Sep 20Is Galenica (VTX:GALE) A Risky Investment?
Aug 30Return Trends At Galenica (VTX:GALE) Aren't Appealing
Jun 15Galenica (VTX:GALE) Could Easily Take On More Debt
Apr 06Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Feb 15Should You Be Adding Galenica (VTX:GALE) To Your Watchlist Today?
Jan 02Does Galenica (VTX:GALE) Have A Healthy Balance Sheet?
Nov 30Returns At Galenica (VTX:GALE) Appear To Be Weighed Down
Oct 24With EPS Growth And More, Galenica (VTX:GALE) Is Interesting
Sep 25Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Aug 24Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Jul 24If You Like EPS Growth Then Check Out Galenica (VTX:GALE) Before It's Too Late
Jun 12Investors Met With Slowing Returns on Capital At Galenica (VTX:GALE)
Apr 07Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Mar 25Galenica AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 11Is Galenica AG (VTX:GALE) The Right Choice For A Smart Dividend Investor?
Feb 27Are Institutions Heavily Invested In Galenica AG's (VTX:GALE) Shares?
Jan 31
Galenica (VTX:GALE) Shareholders Have Enjoyed A 25% Share Price Gain
Jan 13Is Galenica (VTX:GALE) Likely To Turn Things Around?
Dec 25Is Galenica (VTX:GALE) A Risky Investment?
Dec 09Is Galenica AG (VTX:GALE) An Attractive Dividend Stock?
Nov 24Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 4,243 | 190 | 238 | N/A | 3 |
| 12/31/2025 | 4,058 | 180 | 217 | N/A | 4 |
| 12/31/2024 | 3,890 | 172 | 195 | N/A | 4 |
| 6/30/2024 | 3,803 | 170 | 181 | 265 | N/A |
| 3/31/2024 | 3,780 | 167 | 165 | 245 | N/A |
| 12/31/2023 | 3,756 | 165 | 149 | 226 | N/A |
| 9/30/2023 | 3,724 | 158 | 140 | 214 | N/A |
| 6/30/2023 | 3,693 | 152 | 130 | 203 | N/A |
| 3/31/2023 | 3,644 | 154 | 149 | 220 | N/A |
| 12/31/2022 | 3,595 | 157 | 167 | 237 | N/A |
| 9/30/2022 | 3,671 | 162 | 168 | 235 | N/A |
| 6/30/2022 | 3,746 | 167 | 168 | 234 | N/A |
| 3/31/2022 | 3,794 | 167 | 221 | 283 | N/A |
| 12/31/2021 | 3,841 | 168 | 273 | 333 | N/A |
| 9/30/2021 | 3,746 | 177 | 259 | 316 | N/A |
| 6/30/2021 | 3,652 | 185 | 244 | 298 | N/A |
| 3/31/2021 | 3,568 | 179 | 206 | 261 | N/A |
| 12/31/2020 | 3,485 | 172 | 169 | 224 | N/A |
| 9/30/2020 | 3,441 | 149 | 177 | 232 | N/A |
| 6/30/2020 | 3,396 | 126 | 185 | 240 | N/A |
| 3/31/2020 | 3,351 | 126 | 191 | 245 | N/A |
| 12/31/2019 | 3,306 | 125 | 197 | 250 | N/A |
| 9/30/2019 | 3,256 | 140 | 155 | 209 | N/A |
| 6/30/2019 | 3,206 | 156 | 114 | 167 | N/A |
| 3/31/2019 | 3,188 | 152 | 120 | 170 | N/A |
| 12/31/2018 | 3,171 | 148 | 126 | 174 | N/A |
| 9/30/2018 | 3,165 | 132 | N/A | N/A | N/A |
| 6/30/2018 | 3,159 | 117 | 115 | 154 | N/A |
| 3/31/2018 | 3,152 | 118 | N/A | 149 | N/A |
| 12/31/2017 | 3,145 | 119 | N/A | 144 | N/A |
| 9/30/2017 | 3,112 | 111 | N/A | N/A | N/A |
| 6/30/2017 | 3,078 | 104 | N/A | 195 | N/A |
| 3/31/2017 | 3,057 | 94 | N/A | 176 | N/A |
| 12/31/2016 | 3,037 | 83 | N/A | 157 | N/A |
| 12/31/2015 | 2,918 | 81 | N/A | 132 | N/A |
| 12/31/2014 | 2,829 | 82 | N/A | 84 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: GALEDas prognostizierte Gewinnwachstum (5.3% pro Jahr) liegt über der Sparquote (0.3%).
Ertrag vs. Markt: GALEDie Erträge des Unternehmens (5.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Swiss (11.3% pro Jahr).
Hohe Wachstumserträge: GALEDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: GALEDie Einnahmen des Unternehmens (4.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swiss (4.2% pro Jahr).
Hohe Wachstumseinnahmen: GALEDie Einnahmen des Unternehmens (4.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: GALEDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12%).